# Cognitive AED Outcomes in Pediatric Localization Related Epilepsy (COPE)

> **NCT01891890** · PHASE3 · TERMINATED · sponsor: **Emory University** · enrollment: 72 (actual)

## Conditions studied

- Epilepsy, Partial
- Epilepsy, Localization Related

## Interventions

- **DRUG:** Oxcarbazepine
- **DRUG:** Levetiracetam
- **DRUG:** Lamotrigine

## Key facts

- **NCT ID:** NCT01891890
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-08
- **Primary completion:** 2015-10-23
- **Final completion:** 2015-10-23
- **Target enrollment:** 72 (ACTUAL)
- **Why stopped:** Poor recruitment
- **Last updated:** 2017-09-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01891890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01891890, "Cognitive AED Outcomes in Pediatric Localization Related Epilepsy (COPE)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01891890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*